FMR1 and fragile X syndrome: We used the study of translational dysregulation in FXS model mice as a proof-of-principle to address the major issues of ribosome profiling for low-input brain samples where the differences between mouse genotypes (i.e. WT and Fmr1 KO) are expected to be small.